CUAMC
ORKA

China Universal Asset Management Company’s Oruka Therapeutics ORKA Stock Holding History

China Universal Asset Management Company’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$914K Buy
9,599
+1,008
+12% +$67.2K 0.05% 214
2026
Q1 		$421K Buy
8,591
+703
+9% +$24.4K 0.03% 273
2025
Q4 		$239K Buy
7,888
+1,323
+20% +$36.9K 0.02% 330
2025
Q3 		$126K Sell
6,565
-955
-13% -$14.2K 0.01% 370
2025
Q2 		$84.3K Buy
7,520
+11
+0.1% +$115 0.01% 376
2025
Q1 		$77K Buy
7,509
+88
+1% +$1.1K 0.01% 381
2024
Q4 		$144K Buy
+7,421
New +$181K 0.01% 357

Other funds holding ORKA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

China Universal Asset Management Company's ORKA Position: Q2 2026 in Review

China Universal Asset Management Company increased its Oruka Therapeutics (ORKA) stake by 12% in Q2 2026, buying an estimated $67.2K and bringing the position to 9,599 shares worth $914K. The position accounts for 0.05% of the portfolio, ranked #214.

China Universal Asset Management Company first reported a position in ORKA in Q4 2024 and has held it in 7 quarters since. 121 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • China Universal Asset Management Company held 9,599 shares of Oruka Therapeutics worth $914K as of Q2 2026.
  • China Universal Asset Management Company bought 1,008 Oruka Therapeutics shares in Q2 2026, an estimated $67.2K.
  • Oruka Therapeutics made up 0.05% of China Universal Asset Management Company's portfolio in Q2 2026, its #214 holding.
  • China Universal Asset Management Company first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 121 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.